Advertisement

Hit Triage: Medicinal Chemistry Strategies to Improve the Odds of Success in Discovery

  • Kevin D. Freeman-CookEmail author
  • Daniel W. KungEmail author
Chapter
Part of the Topics in Medicinal Chemistry book series (TMC, volume 5)

Abstract

This chapter describes the process of collecting and analyzing information in order to make decisions which help a project move through a key early stage in drug discovery. It explains, in general, the sources of hits for a drug discovery program and explores the link between potency and efficiency in evaluating lead matter. The chapter then illustrates the collection of both pharmacokinetic data as well as safety data, and describes the relevance of that data and the process of using it to make decisions. Of course, there is no one “right” or “wrong” way to do the work contained in this chapter, but the practice of efficiently building a network of information on compounds, and then using that to make informed decisions can help to shift the odds of success in drug discovery.

Keywords

Efficiency Hit Safety Series Triage 

References

  1. 1.
    Gillespie P, Goodnow RA Jr (2004) The hit-to-lead process in drug discovery. In: Doherty A (ed) Annual reports in medicinal chemistry. Elsevier, Oxford, p 293Google Scholar
  2. 2.
    Keseru GM, Makara GM (2006) Drug Discov Today 11:741CrossRefGoogle Scholar
  3. 3.
    Leach AR, Hann MM, Burrows JN, Griffen EJ (2006) Mol Biosyst 2:429CrossRefGoogle Scholar
  4. 4.
    Bleicher KH, Bohm H-J, Muller K, Alanine AI (2003) Nat Rev Drug Discov 2:369CrossRefGoogle Scholar
  5. 5.
    Williams DH, Stephens E, O'Brien DP, Zhou M (2004) Angew Chem Int Ed Engl 43:6596CrossRefGoogle Scholar
  6. 6.
    Nassar A-EF, Lopez-Anaya A (2004) Curr Opin Drug Discov 7:126Google Scholar
  7. 7.
    Lundqvist T (2005) Curr Opin Drug Discov 8:513Google Scholar
  8. 8.
    Carr RA, Congreve M, Murray CW, Rees DC (2005) Drug Discov Today 10:987CrossRefGoogle Scholar
  9. 9.
    Stewart L, Clark R, Behnke C (2002) Drug Discov Today 7:187CrossRefGoogle Scholar
  10. 10.
    Goodwill KE, Tennant MG, Stevens RC (2001) Drug Discov Today 6:S113CrossRefGoogle Scholar
  11. 11.
    Rees DC, Congreve M, Murray CW, Carr R (2004) Nat Rev Drug Discov 3:660CrossRefGoogle Scholar
  12. 12.
    Laird ER, Blake JF (2004) Curr Opin Drug Discov 7:354Google Scholar
  13. 13.
    Klebe G (2006) Drug Discov Today 11:580CrossRefGoogle Scholar
  14. 14.
    Zartler ER, Mo H (2007) Curr Top Med Chem 7:1592CrossRefGoogle Scholar
  15. 15.
    Hajduk PJ, Gerfin T, Boehlen J-M, Haeberli M, Marek D, Fesik SW (1999) J Med Chem 42:2315CrossRefGoogle Scholar
  16. 16.
    Dalvit C, Flocco M, Knapp S, Mostardini M, Perego R, Stockman BJ, Veronesi M, Varasi M (2002) J Am Chem Soc 124:7702CrossRefGoogle Scholar
  17. 17.
    Liu B, Li S, Hu J (2004) Am J Pharmacogenomics 4:263CrossRefGoogle Scholar
  18. 18.
    Boozer C, Kim G, Cong S, Guan HW, Londergan T (2006) Curr Opin Biotech 17:400CrossRefGoogle Scholar
  19. 19.
    Rich R, Hoth LR, Goeghegan KF, Brown TA, LeMotte PK, Simons SP, Hensley P, Myszka DG (2002) Proc Natl Acad Sci USA 99:8562CrossRefGoogle Scholar
  20. 20.
    Cooper MA (2006) Drug Discov Today 11:1068CrossRefGoogle Scholar
  21. 21.
    Doyle ML (1997) Curr Opin Biotech 8:31CrossRefGoogle Scholar
  22. 22.
    Weber PC, Salemme FR (2003) Curr Opin Struct Biol 13:115CrossRefGoogle Scholar
  23. 23.
    Dowling MR, Charlton SJ (2006) Br J Pharmacol 148:927CrossRefGoogle Scholar
  24. 24.
    Huber W (2005) J Mol Recognit 18:273CrossRefGoogle Scholar
  25. 25.
    Cik M, Jurzak MR (2006) High-throughput and high content screening. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.32Google Scholar
  26. 26.
    Schnurr B, Ahrens T, Regenass U (2006) Optical assays in drug discovery In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.27Google Scholar
  27. 27.
    Ullmann D (2006) Fluorescence screening assays. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.28Google Scholar
  28. 28.
    Weissman A, Keefer J, Miagkov A, Sathyamoorthy M, Perschke S, Wang FL (2006) Cell-based screening assays. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.29Google Scholar
  29. 29.
    Kuntz ID, Sharp KA, Kollman PA (1999) Proc Natl Acad Sci USA 96:9997CrossRefGoogle Scholar
  30. 30.
    Hopkins AL, Groom CR, Alex A (2004) Drug Discov Today 9:430CrossRefGoogle Scholar
  31. 31.
    Hajduk PJ (2006) J Med Chem 49:6972CrossRefGoogle Scholar
  32. 32.
    Lipinski CA, Lombardo F, Dominy BW, Freeny PJ (1997) Adv Drug Deliv Rev 23:3CrossRefGoogle Scholar
  33. 33.
    Lipinski CA (2001) J Pharmacol Toxicol 44:235CrossRefGoogle Scholar
  34. 34.
    Hajduk PJ, Greer J (2007) Nat Rev Drug Discov 6:211CrossRefGoogle Scholar
  35. 35.
    Teague SJ, Davis AM, Leeson PD, Oprea T (1999) Angew Chem Int Ed Engl 38:3743CrossRefGoogle Scholar
  36. 36.
    Hann MM, Leach AR, Harper G (2001) J Chem Inf Comput Sci 41:856CrossRefGoogle Scholar
  37. 37.
    Proudfoot JR (2002) Bioorg Med Chem Lett 12:1647CrossRefGoogle Scholar
  38. 38.
    Wunberg T, Hendrix M, Hillisch A, Lobell M, Meier H, Schmeck C, Wild H, Hinzen B (2006) Drug Discov Today 11:175CrossRefGoogle Scholar
  39. 39.
    Hann MM, Oprea TI (2004) Curr Opin Chem Biol 8:255CrossRefGoogle Scholar
  40. 40.
    Van de Waterbeemd H, Smith DA, Beaumont K, Walker DK (2001) J Med Chem 44:1313CrossRefGoogle Scholar
  41. 41.
    Van de Waterbeemd H, Smith DA, Jones BC (2001) J Comp Aid Mol Des 15:273CrossRefGoogle Scholar
  42. 42.
    Riley RJ, Martin IJ, Cooper AE (2002) Curr Drug Metab 3:527CrossRefGoogle Scholar
  43. 43.
    Venkatakrishnan K, von Moltke LL, Obach RS, Greenblatt DJ (2003) Curr Drug Metab 4:423CrossRefGoogle Scholar
  44. 44.
    Di L, Kerns EH (2005) Curr Opin Drug Discov Dev 8:495Google Scholar
  45. 45.
    Parmentier Y, Bossant M-J, Bertrand M, Walther B (2006) In vitro studies of drug metabolism. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.10Google Scholar
  46. 46.
    Trager WF (2006) Principles of drug metabolism 1: redox reactions. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.05Google Scholar
  47. 47.
    Testa B (2006) Principles of drug metabolism 2: hydrolysis and conjugation reactions. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.06Google Scholar
  48. 48.
    Lin JH, Wong BK (2002) Curr Drug Metab 3:623CrossRefGoogle Scholar
  49. 49.
    Obach RS (2001) Curr Opin Drug Discov Dev 4:36Google Scholar
  50. 50.
    Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, Tucker GT, Rostami-Hodjegan A (2007) Curr Drug Metab 8:33CrossRefGoogle Scholar
  51. 51.
    Brown HS, Griffin M, Houston JB (2007) Drug Metab and Dispos 35:293CrossRefGoogle Scholar
  52. 52.
    Grime K, Riley RJ (2006) Curr Drug Metab 7:251CrossRefGoogle Scholar
  53. 53.
    Nassar A-EF, Kamel AM, Clarimont C (2004) Drug Discov Today 9:1020CrossRefGoogle Scholar
  54. 54.
    Balimane PV, Han Y-H, Chong S (2006) AAPS J 8:E1CrossRefGoogle Scholar
  55. 55.
    Artursson P, Neuhoff S, Matsson P, Tavelin S (2006) Passive permeability and active transport models for the prediction of oral absorption. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.11Google Scholar
  56. 56.
    Kansy M, Senner F, Gubernator K (1998) J Med Chem 41:1007CrossRefGoogle Scholar
  57. 57.
    Galinis-Luciani D, Nguyen L, Yazdanian M (2007) J Pharm Sci 96:2886CrossRefGoogle Scholar
  58. 58.
    Avdeef A, Bendels S, Di L, Faller B, Kansy M, Sugano K, Yamauchi Y (2007) J Pharm Sci 96:2893CrossRefGoogle Scholar
  59. 59.
    Yu X-Q, Xue CC, Wang G, Zhou S-F (2007) Curr Drug Metab 8:787CrossRefGoogle Scholar
  60. 60.
    Fearn RA, Hirst BH (2006) Environ Toxicol Pharmacol 21:168CrossRefGoogle Scholar
  61. 61.
    Abbott NJ (2006) In vitro models for examining and predicting brain uptake of drugs. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.13Google Scholar
  62. 62.
    Malkia A, Murtomaki L, Urtti A, Kontturi K (2004) Eur J Pharm Sci 23:13CrossRefGoogle Scholar
  63. 63.
    Alsenz J, Kansy M (2007) Adv Drug Deliv Rev 59:546CrossRefGoogle Scholar
  64. 64.
    Bergstrom CAS, Wassvik CM, Johansson K, Hubatsch I (2007) J Med Chem 50:5858CrossRefGoogle Scholar
  65. 65.
    Kola I, Landis J (2004) Nat Rev Drug Discov 3:711CrossRefGoogle Scholar
  66. 66.
    Pearlstein R, Vaz R, Rampe D (2003) J Med Chem 46:2017CrossRefGoogle Scholar
  67. 67.
    Raschi E, Vasina V, Poluzzi E, De Ponti F (2008) Pharmacol Res 57:181CrossRefGoogle Scholar
  68. 68.
    Snyders DJ, Chaudhury A (1996) Mol Pharmacol 49:949Google Scholar
  69. 69.
    Kiehn J, Lacerda AE, Wible B, Brown AM (1996) Circulation 94:2572CrossRefGoogle Scholar
  70. 70.
    Dubin AE, Nasser N, Rohrbacher J, Hermans AN, Marrannes R, Grantham C, Van Rossem K, Cik M, Chaplan SR, Gallacher D, Xu J, Guia A, Byrne NG, Mathes C (2005) J Biomol Screen 10:168CrossRefGoogle Scholar
  71. 71.
    Raab CE, Butcher JW, Connolly TM, Karczewski J, Yu N, Staskiewicz S, Liverton N, Dean DC, Melillo DG (2006) Bioorg Med Chem Lett 16:1692CrossRefGoogle Scholar
  72. 72.
    Singleton DH (2007) J Med Chem 50:2391CrossRefGoogle Scholar
  73. 73.
    Fernandez D, Ghanta A, Kauffman GW, Sanguinetti MC (2004) J Biol Chem 279:10120CrossRefGoogle Scholar
  74. 74.
    Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) J Med Chem 45:3844CrossRefGoogle Scholar
  75. 75.
    Aronov A (2006) J Med Chem 49:6917CrossRefGoogle Scholar
  76. 76.
    Cianchetta G, Li Y, Kang J, Rampe D, Fravolini A, Cruciani G, Vaz RJ (2005) Bioorg Med Chem Lett 15:3637CrossRefGoogle Scholar
  77. 77.
    Song M, Clark M (2006) J Chem Inf Model 46:392CrossRefGoogle Scholar
  78. 78.
    Waring MJ, Johnstone C (2007) Bioorg Med Chem Lett 17:1759CrossRefGoogle Scholar
  79. 79.
    Muto S, Miyata K, Tsutsumibata C, Daigo H, Ooro T, Sugiura K, Baba H, Uno Y (2006) Top Issues Appl Microbiol Biotech 1Google Scholar
  80. 80.
    Kirpnick Z, Homiski M, Rubitski E, Repnevskaya M, Howlett N, Aubrecht J, Schiestl RH (2005) Mutat Res 582:116CrossRefGoogle Scholar
  81. 81.
    Avlasevich SL, Bryce SM, Cairns SE, Dertinger SD (2006) Environ Mol Mutagen 47:56CrossRefGoogle Scholar
  82. 82.
    Greene N (2006) Computational models to predict toxicity. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5Google Scholar
  83. 83.
    Egan WJ, Zlokarnik G, Grootenhuis PDJ (2004) Drug Discov Today Tech 1:381CrossRefGoogle Scholar
  84. 84.
    Contrera JF, Matthews EJ, Kruhlak NL, Benz RD (2005) Regul Toxicol Pharmacol 43:313CrossRefGoogle Scholar
  85. 85.
    Murray M (2005) Mod Biopharm 4:1603CrossRefGoogle Scholar
  86. 86.
    Hayashi M, Kamata E, Hirose A, Takahashi M, Morita T, Ema M (2005) Mutat Res 588:129CrossRefGoogle Scholar
  87. 87.
    Matthews EJ, Kruhlak NL, Cimino MC, Benz RD, Contrera JF (2006) Regul Toxicol Pharmacol 44:97CrossRefGoogle Scholar
  88. 88.
    Didziapetris R, Reynolds DP, Japertas P, Zmuidinavicius D, Petrauskas A (2006) Curr Comp Drug Des 2:95CrossRefGoogle Scholar
  89. 89.
    Snyder RD (2007) Mutat Res 623:72CrossRefGoogle Scholar
  90. 90.
    Hop CECA, Kalgutkar A, Soglia J (2006) Annu Rep Med Chem 41:369CrossRefGoogle Scholar
  91. 91.
    Williams DP, Park BK (2003) Drug Discov Today 8:1044CrossRefGoogle Scholar
  92. 92.
    Walgren JL, Mitchell MD, Thompson DC (2005) Crit Rev Toxicol 35:325CrossRefGoogle Scholar
  93. 93.
    Park BK, Kitteringham NR, Maggs JL, Pirmohamed M, Williams DP (2005) Annu Rev Pharmacol Toxicol 45:177CrossRefGoogle Scholar
  94. 94.
    Roth RA, Luyendyk JP, Maddox JF, Ganey PE (2003) J Pharmacol Exp Ther 307Google Scholar
  95. 95.
    Kalgutkar AS, Obach RS, Maurer TS (2007) Curr Drug Metab 8:407CrossRefGoogle Scholar
  96. 96.
    Blagg J (2006) Annu Rep Med Chem 41:369CrossRefGoogle Scholar
  97. 97.
    Soglia JR, Harriman SP, Zhao S, Barberia J, Cole MJ, Boyd JG, Contillo LG (2004) J Pharm Biomed Anal 36:105CrossRefGoogle Scholar
  98. 98.
    Zheng J, Ma L, Xin B, Olah T, Griffith Humphreys W, Zhu M (2007) Chem Res Toxicol 20:757CrossRefGoogle Scholar
  99. 99.
    Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier M-C, Deprez B (2001) J Med Chem 44:3391CrossRefGoogle Scholar
  100. 100.
    Fliri AF, Loging WT, Thadeio PF, Volkmann RA (2005) Proc Natl Acad Sci USA 102:261CrossRefGoogle Scholar
  101. 101.
    Schnecke V, Bostrom J (2006) Drug Discov Today 11:43CrossRefGoogle Scholar
  102. 102.
    Beresford AP, Segall M, Tarbit MH (2004) Curr Opin Drug Discov Dev 7:36Google Scholar
  103. 103.
    Ekins S, Swaan PW (2004) Development of computational models for enzymes, transporters, channels, and receptors relevant to ADME/tox. In: Lipkowitz KB, Larter R, Cundari TR (eds) Reviews in computational chemistry, vol. 20. Wiley, Hoboken, NJ, chap 6CrossRefGoogle Scholar
  104. 104.
    Penzotti J, Landrum GA, Putta S (2004) Curr Opin Drug Discov Dev 7:49Google Scholar
  105. 105.
    Bergstrom CAS (2005) Expert Opin Drug Metab Toxicol 1:613CrossRefGoogle Scholar
  106. 106.
    Yu H, Adedoyin A (2003) Drug Discov Today 8:852CrossRefGoogle Scholar
  107. 107.
    Davies JW, Glick M, Jenkins JL (2006) Curr Opin Chem Biol 10:343CrossRefGoogle Scholar
  108. 108.
    Faller B, Ertl P (2007) Adv Drug Deliv Rev 59:533CrossRefGoogle Scholar
  109. 109.
    Delaney JS (2005) Drug Discov Today 10:289CrossRefGoogle Scholar
  110. 110.
    Bergstrom CAS (2005) Expert Opin Drug Metab Toxicol 1:613CrossRefGoogle Scholar
  111. 111.
    Arimoto R (2006) Curr Top Med Chem 6:1609CrossRefGoogle Scholar
  112. 112.
    Snyder RD, Smith MD (2005) Drug Discov Today 10:1119CrossRefGoogle Scholar
  113. 113.
    Clark DE (2005) Computational prediction of blood-brain barrier permeation. In Doherty A (ed) Annual reports in medicinal chemistry. Elsevier, Oxford, p 413Google Scholar
  114. 114.
    Hutzler JM, Messing DM, Wienkers LC (2005) Curr Opin Drug Discov Dev 8:51Google Scholar
  115. 115.
    Ekins S, Balakin KV, Savchuk N, Ivanenkov Y (2006) J Med Chem 49:5059CrossRefGoogle Scholar
  116. 116.
    Johnson SR, Yue H, Conder ML, Shi H, Doweyko AM, Lloyd J, Levesque P (2007) Bioorg Med Chem 15:6182CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.ClintonUSA
  2. 2.SalemUSA

Personalised recommendations